Literature DB >> 6290745

Suppressor cells assayed by numerical and functional tests in chronic renal failure.

J E Lortan, P Kiepiela, H M Coovadia, Y K Seedat.   

Abstract

Suppressor cells were assayed by numerical and functional tests in adults on chronic hemodialysis. Peripheral blood mononuclears (PBM) were classified as total T-cells by E-rosettes and by the monoclonal antibody OKT3, as T-cell subsets by OKT4 (inducer/helper T-cells) and OKT8 (cytotoxic/suppressor T-cells) and as B-cells by the presence of surface immunoglobulin. The suppressive effect of PBM pretreated with either Concanavalin A (Con A), sodium periodate, or serum rich in immune complexes, on normal homologous phytohemagglutinin (PHA) lymphocyte transformation, was determined. Usual tests of T-cell function were not done. T lymphopenia was due to significant diminution (P less than 0.002) in numbers of OKT4+ cells in patients (516 +/- 44 cells/mm3, mean +/- sem) as compared to controls (906 +/- 96 cells/mm3). The number of OKT8+ cells in patients was not different from normal although their percentage (45 +/- 4%) was slightly higher than controls (36 +/- 5%) (P less than 0.10). Suppressor activity using only a suboptimal dose of Con A (5 micrograms/ml), was significantly lower (P less than 0.002) in uremic patients (36 +/- 12%) than in controls (67 +/- 7%). An important finding was that no significant correlations were detected between the numerical and functional assays of suppression used or between any of these immunological tests and biochemical parameters studied. The implications of these results for immunoparesis in uremia are discussed with particular reference to the discordance between marker and functional assays of suppressor cells.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6290745     DOI: 10.1038/ki.1982.152

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  7 in total

1.  Presence of preactivated T cells in hemodialyzed patients: their possible role in altered immunity.

Authors:  L Chatenoud; B Dugas; G Beaurain; M Touam; T Drueke; A Vasquez; P Galanaud; J F Bach; J F Delfraissy
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

Review 2.  The use of vaccines in renal failure.

Authors:  D W Johnson; S J Fleming
Journal:  Clin Pharmacokinet       Date:  1992-06       Impact factor: 6.447

3.  In vitro analysis of B lymphocyte function in uraemia.

Authors:  D Degiannis; A M Mowat; E Galloway; D Tsakiris; J D Briggs; B J Junor; D M Parrott
Journal:  Clin Exp Immunol       Date:  1987-11       Impact factor: 4.330

4.  Immunoregulation in glomerulonephritis, Henoch--Schonlein purpura and lupus nephritis.

Authors:  K M Bannister; P A Drew; A R Clarkson; A J Woodroffe
Journal:  Clin Exp Immunol       Date:  1983-08       Impact factor: 4.330

5.  Thymus lymphocytes in uraemic rats and the effect of thymosin fraction 5 in vivo.

Authors:  S Ikemoto; M Kamizuru; N Hayahara; S Okamoto; S Wada; T Kishimoto; M Maekawa
Journal:  Clin Exp Immunol       Date:  1992-02       Impact factor: 4.330

6.  Studies on IL-2 production and T-cell colony forming unit in patients with chronic renal failure.

Authors:  S K Ha; H S Cho; H Y Lee; H S Kim; K H Choi; D S Han; B K Lee; J D Kim
Journal:  Korean J Intern Med       Date:  1993-07       Impact factor: 2.884

7.  CD19+ B-Cells, a New Biomarker of Mortality in Hemodialysis Patients.

Authors:  María Molina; Luis M Allende; Luis E Ramos; Eduardo Gutiérrez; Daniel E Pleguezuelo; Eduardo R Hernández; Francisco Ríos; Cristina Fernández; Manuel Praga; Enrique Morales
Journal:  Front Immunol       Date:  2018-06-15       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.